iZafe Group AB (FRA:M02) Interest Expense: €-0.12 Mil (TTM As of Mar. 2026)

What is iZafe Group AB Interest Expense?

iZafe Group AB FRA:M02 -5.06% 48 Interest Expense is €-0.12 Mil as of Mar. 2026. GuruFocus rates FRA:M02 with a GF Score™ of 48/100 and a GF Value™ of €0.04 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. iZafe Group AB's interest expense for the three months ended in Mar. 2026 was € -0.07 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.12 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. iZafe Group AB's Operating Income for the three months ended in Mar. 2026 was € -0.55 Mil. iZafe Group AB's Interest Expense for the three months ended in Mar. 2026 was € -0.07 Mil. iZafe Group AB did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

iZafe Group AB (FRA:M02) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

iZafe Group AB's Interest Expense for the three months ended in Mar. 2026 was €-0.07 Mil. Its Operating Income for the three months ended in Mar. 2026 was €-0.55 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was €0.02 Mil.

iZafe Group AB's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

iZafe Group AB did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

iZafe Group AB Interest Expense Historical Data

* Premium members only.

The historical data trend for iZafe Group AB's Interest Expense can be seen below:

iZafe Group AB Interest Expense Chart

iZafe Group AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-0.29

-0.02

-0.10

-0.07

iZafe Group AB Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Expense	Get a 7-Day Free Trial															-0.02	-0.02	-0.02	0.00	-0.07

48GF Score

iZafe Group AB FRA:M02

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

iZafe Group AB Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.12 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of €-0.12 Mil mean?

iZafe Group AB (FRA:M02) has a Interest Expense of €-0.12 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on iZafe Group AB and its competitors.

Is iZafe Group AB's Interest Expense too high?

iZafe Group AB's current Interest Expense is €-0.12 Mil. Overall, iZafe Group AB has a GF Score™ of 48/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does iZafe Group AB's Interest Expense compare to ISRG and BDX?

iZafe Group AB's Interest Expense of €-0.12 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Medical Devices & Instruments company?

A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on iZafe Group AB and its competitors. iZafe Group AB's current Interest Expense is €-0.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is iZafe Group AB stock overvalued right now?

Based on GuruFocus' analysis, iZafe Group AB (FRA:M02) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.04, compared to a current price of €0.03 — trading 15.5% below its estimated fair value. The current Interest Expense is €-0.12 Mil. iZafe Group AB's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For iZafe Group AB (FRA:M02), the current Interest Expense is €-0.12 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is iZafe Group AB (FRA:M02) Overvalued in 2026?

Based on GuruFocus' analysis, iZafe Group AB stock appears to be undervalued. The current stock price of €0.03 is trading 15.5% below its estimated GF Value™ of €0.04. GuruFocus considers iZafe Group AB to be Modestly Undervalued.

Key valuation signals for FRA:M02:

Interest Expense: €-0.12 Mil
GF Value™: €0.04 vs. price of €0.03 (15.5% below fair value)
GF Score™: 48/100 with 2 warning signs

No single metric tells the full story. See the FRA:M02 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

iZafe Group AB Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies OSTO:ORTI A NGM:PRLD XSAT:SERV XSAT:ODIN OSTO:S2M XSAT:BIOWKS ISRG XPAR:EL TSE:7741 BDX XSWX:ALC MDLN RMD WST TSE:4543 XPAR:DIM XSWX:STMN XTER:SRT OCSE:COLO B NZSE:FPH

Other Exchanges IZAFE B:Sweden

Address David Bagares Gata 3, Stockholm, SWE, 111 38

Website https://www.izafe.se

iZafe Group AB is a Developer of a digital medication dispensing system designed to enhance patient safety and reduce medication errors in home healthcare. The company offers a smart medication robot with automated dispensing and remote monitoring, enabling public and private healthcare providers in Sweden, the Nordics, and international markets, improved treatment adherence and reduced caregiver workload.

48GF Score

Get the complete analysis for FRA:M02

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.03

Price

€0.04

GF Value

View FRA:M02 Analysis

See Interest Expense data for all stocks →